These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
402 related items for PubMed ID: 2944574
1. Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line. Poulin R, Labrie F. Cancer Res; 1986 Oct; 46(10):4933-7. PubMed ID: 2944574 [Abstract] [Full Text] [Related]
2. Adrenal C19-5-ene steroids induce full estrogenic responses in rat pituitary gonadotrophs. Simard J, Labrie F. J Steroid Biochem; 1987 May; 26(5):539-46. PubMed ID: 2953941 [Abstract] [Full Text] [Related]
3. Estrogenic effects of physiological concentrations of 5-androstene-3 beta, 17 beta-diol and its metabolism in MCF7 human breast cancer cells. Adams J, Garcia M, Rochefort H. Cancer Res; 1981 Nov; 41(11 Pt 1):4720-6. PubMed ID: 6458355 [Abstract] [Full Text] [Related]
4. Influence of dehydroepiandrosterone and 5-en-androstene-3 beta, 17 beta-diol on the growth of MCF-7 human breast cancer cells induced by 17 beta-estradiol. Boccuzzi G, Brignardello E, di Monaco M, Forte C, Leonardi L, Pizzini A. Anticancer Res; 1992 Nov; 12(3):799-803. PubMed ID: 1535770 [Abstract] [Full Text] [Related]
5. Full oestrogenic activity of C19-delta 5 adrenal steroids in rat pituitary lactotrophs and somatotrophs. Simard J, Vincent A, Duchesne R, Labrie F. Mol Cell Endocrinol; 1988 Feb; 55(2-3):233-42. PubMed ID: 2965660 [Abstract] [Full Text] [Related]
6. Adrenal precursor C19 steroids are potent stimulators of growth of androgen-sensitive mouse mammary carcinoma Shionogi cells in vitro. Bégin D, Luthy IA, Labrie F. Mol Cell Endocrinol; 1988 Aug; 58(2-3):213-9. PubMed ID: 2974815 [Abstract] [Full Text] [Related]
7. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha. Maggiolini M, Donzé O, Jeannin E, Andò S, Picard D. Cancer Res; 1999 Oct 01; 59(19):4864-9. PubMed ID: 10519397 [Abstract] [Full Text] [Related]
8. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Katzenellenbogen BS, Kendra KL, Norman MJ, Berthois Y. Cancer Res; 1987 Aug 15; 47(16):4355-60. PubMed ID: 3607768 [Abstract] [Full Text] [Related]
9. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival. Menendez JA, Oza BP, Colomer R, Lupu R. Int J Oncol; 2005 Jun 15; 26(6):1507-15. PubMed ID: 15870863 [Abstract] [Full Text] [Related]
10. C19 adrenal steroids enhance prostaglandin F2 alpha output by human endometrium in vitro. Markiewicz L, Gurpide E. Am J Obstet Gynecol; 1988 Aug 15; 159(2):500-4. PubMed ID: 2970223 [Abstract] [Full Text] [Related]
11. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro. Reddel RR, Sutherland RL. Cancer Res; 1987 Oct 15; 47(20):5323-9. PubMed ID: 3652038 [Abstract] [Full Text] [Related]
12. Extensive esterification of adrenal C19-delta 5-sex steroids to long-chain fatty acids in the ZR-75-1 human breast cancer cell line. Poulin R, Poirier D, Merand Y, Thériault C, Bélanger A, Labrie F. J Biol Chem; 1989 Jun 05; 264(16):9335-43. PubMed ID: 2524485 [Abstract] [Full Text] [Related]
13. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells. Sheen YY, Ruh TS, Mangel WF, Katzenellenbogen BS. Cancer Res; 1985 Sep 05; 45(9):4192-9. PubMed ID: 4040807 [Abstract] [Full Text] [Related]
14. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells. He D, Falany CN. Prostate; 2007 Sep 01; 67(12):1318-29. PubMed ID: 17626250 [Abstract] [Full Text] [Related]
15. Biological effects of adrenal androgens on MCF-7 and BT-20 human breast cancer cells. Najid A, Habrioux G. Oncology; 1990 Sep 01; 47(3):269-74. PubMed ID: 2140441 [Abstract] [Full Text] [Related]
16. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study. Chen J, Wang WQ, Lin SX. J Steroid Biochem Mol Biol; 2013 Sep 01; 137():316-21. PubMed ID: 23416106 [Abstract] [Full Text] [Related]
17. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Osborne CK, Hobbs K, Clark GM. Cancer Res; 1985 Feb 01; 45(2):584-90. PubMed ID: 3967234 [Abstract] [Full Text] [Related]
18. Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue. Poortman J, Prenen JA, Schwarz F, Thijssen JH. J Clin Endocrinol Metab; 1975 Mar 01; 40(3):373-9. PubMed ID: 163841 [Abstract] [Full Text] [Related]
19. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer. Simard J, Dauvois S, Haagensen DE, Lévesque C, Mérand Y, Labrie F. Endocrinology; 1990 Jun 01; 126(6):3223-31. PubMed ID: 2351114 [Abstract] [Full Text] [Related]
20. High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy. Morris KT, Toth-Fejel S, Schmidt J, Fletcher WS, Pommier RF. Surgery; 2001 Dec 01; 130(6):947-53. PubMed ID: 11742322 [Abstract] [Full Text] [Related] Page: [Next] [New Search]